Kevin Gorman | Chief Executive Officer |
Jane Sorensen | Head, Investor Relations |
Matt Abernethy | Chief Financial Officer |
Eiry Roberts | Chief Medical Officer |
Eric Benevich | Chief Commercial Officer |
Kyle Gano | Chief Business Development Officer |
Geoff Meacham | Barclays |
Jack Allen | Robert W. Baird |
Paul Matteis | Stifel |
Tazeen Ahmad | Bank of America |
Biren Amin | Jefferies |
Ravi Mehrotra | Evercore ISI |
Phil Nadeau | Cowen & Co. |
Anupam Rama | JPMorgan |
Charles Duncan | Cantor Fitzgerald |
Jay Olson | Oppenheimer |
Paul Choi | Goldman Sachs |
Marc Goodman | SVB Leerink |
Alan Carr | Needham & Co. |
David Amsellem | Piper Jaffray |
Sumant Kulkarni | Canaccord |
Hello and thank you for joining the Neurocrine Biosciences Reports First Quarter 2019 Results. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during a Q&A session. [Operator Instructions] Please note this call may be being recorded. It is now my pleasure to turn the call over to Kevin Gorman, CEO.